Skip to content

Treatment Response to Rehabilitation in Patients With Schizophrenia

Treatment Response to Rehabilitation in Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00063336
Enrollment
46
Registered
2003-06-27
Start date
2001-12-31
Completion date
2005-11-30
Last updated
2013-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

This study will examine the ways in which schizophrenia-related symptoms affect response to a rehabilitation program for people with schizophrenia.

Detailed description

Patients with schizophrenia often suffer neurocognitive impairment and psychosocial and vocational difficulties. This study will help identify those patients most likely to benefit from existing behavioral treatments and provide clues for how to modify treatments for those who do not benefit. Two studies will be conducted. The first will investigate the relationship of symptoms and neurocognitive variables at study entry to psychosocial and vocational status 2 years later. The second study will investigate the relationship of symptoms and neurocognitive variables at study entry to treatment response in patients assigned to either a cognitive remediation track or a computer skills track as part of their rehabilitation treatment. Both the cognitive remediation and computer skills training programs will last 4 to 6 months. Participants will be assessed pre- and post-treatment. Neuropsychological, psychosocial and vocational status will be measured.

Interventions

BEHAVIORALCognitive Remediation

A computerized cognitive rehabilitation treatment with day-program activities

BEHAVIORALComputer-skills training

A computerized cognitive rehabilitation treatment with day-program activities

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Hartford Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* DSM-IV criteria for schizophrenia or schizoaffective disorder * In need of intensive outpatient care * Treatment with atypical antipsychotic medication for a minimum of 6 months prior to study entry

Exclusion criteria

* Auditory or visual impairment * Mental retardation (IQ less than 70) * Traumatic brain injury with loss of consciousness * Presence or history of any neurological illness that may affect brain physiology * Lack of proficiency in English * Concurrent substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Neuropsychological test battery, including measures of visual, verbal memory, and problem-solving abilitiesMeasured pre- and post-treatment
Schizophrenia symptomsMeasured pre- and post-treament
UCSD Performance-Based Skills AssessmentMeasured pre- and post-treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026